Rep. Jared Moskowitz Purchases HCA Healthcare, Inc. (NYSE:HCA) Shares

Representative Jared Moskowitz (Democratic-Florida) recently bought shares of HCA Healthcare, Inc. (NYSE:HCA). In a filing disclosed on July 26th, the Representative disclosed that they had bought between $1,001 and $15,000 in HCA Healthcare stock on June 17th. The trade occurred in the Representative’s “MORGAN STANLEY ACTIVE ASSETS (1)” account.

Representative Jared Moskowitz also recently made the following trade(s):

• Purchased $1,001 – $15,000 in shares of Applied Materials (NASDAQ:AMAT) on 6/18/2026.
• Purchased $1,001 – $15,000 in shares of Microsoft (NASDAQ:MSFT) on 6/17/2026.
• Purchased $1,001 – $15,000 in shares of Home Depot (NYSE:HD) on 6/17/2026.
• Purchased $1,001 – $15,000 in shares of Monster Beverage (NASDAQ:MNST) on 6/17/2026.
• Sold $1,001 – $15,000 in shares of S&P Global (NYSE:SPGI) on 6/17/2026.
• Purchased $1,001 – $15,000 in shares of Meta Platforms (NASDAQ:META) on 6/17/2026.
• Purchased $1,001 – $15,000 in shares of SpaceX (NASDAQ:SPCX) on 6/12/2026.
• Sold $1,001 – $15,000 in shares of Cencora (NYSE:COR) on 5/6/2026.
• Purchased $1,001 – $15,000 in shares of Gilead Sciences (NASDAQ:GILD) on 5/6/2026.

HCA Healthcare Price Performance

HCA Healthcare stock traded up $8.50 during trading on Wednesday, reaching $409.23. 199,934 shares of the company were exchanged, compared to its average volume of 1,348,160. HCA Healthcare, Inc. has a 52-week low of $353.99 and a 52-week high of $556.52. The company has a market capitalization of $88.60 billion, a P/E ratio of 13.70, a PEG ratio of 1.41 and a beta of 1.10. The stock’s 50 day simple moving average is $387.44 and its two-hundred day simple moving average is $449.94.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings results on Friday, July 24th. The company reported $7.59 EPS for the quarter, beating the consensus estimate of $7.56 by $0.03. HCA Healthcare had a net margin of 8.77% and a negative return on equity of 244.79%. The company had revenue of $20.23 billion for the quarter, compared to analyst estimates of $19.76 billion. During the same period in the prior year, the firm posted $6.84 earnings per share. The firm’s revenue was up 8.7% on a year-over-year basis. As a group, equities analysts forecast that HCA Healthcare, Inc. will post 29.45 earnings per share for the current year.

HCA Healthcare Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, September 30th. Shareholders of record on Wednesday, September 16th will be given a dividend of $0.78 per share. The ex-dividend date is Wednesday, September 16th. This represents a $3.12 dividend on an annualized basis and a yield of 0.8%. HCA Healthcare’s dividend payout ratio is currently 10.45%.

Hedge Funds Weigh In On HCA Healthcare

Large investors have recently added to or reduced their stakes in the business. Trifecta Capital Advisors LLC purchased a new position in shares of HCA Healthcare during the 2nd quarter worth about $84,000. Summit Global Investments purchased a new stake in HCA Healthcare during the second quarter valued at about $237,000. Oppenheimer Asset Management Inc. purchased a new stake in shares of HCA Healthcare during the 2nd quarter worth about $1,431,000. Bryn Mawr Trust Advisors LLC purchased a new stake in shares of HCA Healthcare during the 2nd quarter valued at about $472,000. Finally, Ballast Inc. purchased a new stake in shares of HCA Healthcare during the second quarter valued at approximately $296,000. 62.73% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

HCA has been the subject of a number of recent analyst reports. Sanford C. Bernstein restated a “market perform” rating on shares of HCA Healthcare in a research report on Wednesday, July 15th. Stephens dropped their target price on shares of HCA Healthcare from $560.00 to $530.00 and set an “overweight” rating for the company in a report on Monday, April 27th. The Goldman Sachs Group decreased their target price on HCA Healthcare from $558.00 to $485.00 and set a “buy” rating on the stock in a research report on Tuesday, July 28th. Weiss Ratings lowered shares of HCA Healthcare from a “buy (b-)” rating to a “hold (c+)” rating in a research report on Tuesday, June 9th. Finally, Morgan Stanley reduced their price target on shares of HCA Healthcare from $425.00 to $380.00 and set an “underweight” rating on the stock in a report on Monday, July 27th. Fourteen investment analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $465.59.

About Representative Moskowitz

Jared Evan Moskowitz (Democratic Party) is a member of the U.S. House, representing Florida’s 23rd Congressional District. He assumed office on January 3, 2023. His current term ends on January 3, 2027.

Moskowitz (Democratic Party) is running for re-election to the U.S. House to represent Florida’s 23rd Congressional District. He declared candidacy for the 2026 election.

Jared Evan Moskowitz was born in Coral Springs, Florida. Moskowitz graduated from Marjory Stoneman Douglas High School. He earned a bachelor’s degree in political science and government from George Washington University in 2003 and a law degree from Nova Southeastern University in 2007. Moskowitz’s career experience includes working as the director of the Florida Division of Emergency Management and general counsel with AshBritt Inc.

HCA Healthcare Company Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.